chr16-84179024-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001243156.2(TAF1C):c.2449G>T(p.Val817Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000621 in 1,610,564 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001243156.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TAF1C | NM_001243156.2 | c.2449G>T | p.Val817Phe | missense_variant | 15/15 | ENST00000566732.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TAF1C | ENST00000566732.6 | c.2449G>T | p.Val817Phe | missense_variant | 15/15 | 2 | NM_001243156.2 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000121 AC: 30AN: 247118Hom.: 0 AF XY: 0.000104 AC XY: 14AN XY: 133984
GnomAD4 exome AF: 0.0000631 AC: 92AN: 1458380Hom.: 1 Cov.: 59 AF XY: 0.0000537 AC XY: 39AN XY: 725594
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152184Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74336
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 10, 2024 | The c.2527G>T (p.V843F) alteration is located in exon 14 (coding exon 13) of the TAF1C gene. This alteration results from a G to T substitution at nucleotide position 2527, causing the valine (V) at amino acid position 843 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at